Locations:
Search
Immunotherapy is preferred initial treatment for majority of patients
Recommendations focus on selecting the right biomarkers for the right setting
Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival
First prospective study looks at endocrine therapy interruption in premenopausal patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia
Distinct molecular features found in five subtypes of disease
Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy
Elevated levels of vWF and FVIII associated with risk of blood clots, severe COVID-19 and death
Study matches momelotinib against danazol
Research supports national guidelines for early-stage breast cancer
Advertisement
Advertisement